Yale University

The EXO-200 detector, part II: Auxiliary systems (2022) Ackerman N, Albert J, Auger M, Auty DJ, Badhrees I, Barbeau PS, Bartoszek L, et al. Journal article Erik Torebjörk, MD PhD, Professor of Clinical Pain Research 1939-2021 Forerunner and lead researcher of human nociceptor research (2022) Handwerker HO, Jorum E, Schady W, Lamotte R, Schmelz M Journal article Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis. (2022) Kuramatsu J, Gerner S, Ziai W, Bardutzky J, Sembill J, Sprügel M, Mrochen A, et al. Journal article Operando Structure-Activity-Stability Relationship of Iridium Oxides during the Oxygen Evolution Reaction (2022) Mom RV, Falling LJ, Kasian O, Algara-Siller G, Teschner D, Crabtree RH, Knop-Gericke A, et al. Journal article Design and performance of the prototype Schwarzschild-Couder telescope camera (2022) Adams CB, Ambrosi G, Ambrosio M, Aramo C, Arlen T, Benbow W, Bertucci B, et al. Journal article nEXO: neutrinoless double beta decay search beyond 10(28) year half-life sensitivity (2022) Adhikari G, Al Kharusi S, Angelico E, Anton G, Arnquist IJ, Badhrees , Bane J, et al. Journal article Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis (2021) Efe C, Lammert C, Tascilar K, Dhanasekaran R, Ebik B, Higuera-De La Tijera F, Caliskan AR, et al. Journal article Search for Majoron-emitting modes of Xe-136 double beta decay with the complete EXO-200 dataset (2021) Al Kharusi S, Anton G, Badhrees , Barbeau PS, Beck D, Belov V, Bhatta T, et al. Journal article Elastin-specific MRI of extracellular matrix-remodelling following hepatic radiofrequency-ablation in a VX2 liver tumor model (2021) Collettini F, Reimann C, Brangsch J, Chapiro J, Savic LJ, Onthank DC, Robinson SP, et al. Journal article Lu-177-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial (2021) Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, et al. Journal article